Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 1,357.53% vs 0.00% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 72.17% vs -77.16% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 71.16% vs -88.06% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -10.81% vs 27.59% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Madrigal Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 55.10% vs 32.82% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 1,357.53% vs 0.00% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 42.21% vs -23.23% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 72.17% vs -77.16% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 40.68% vs -18.47% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 71.16% vs -88.06% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -5.71% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -10.81% vs 27.59% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






